vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and MIDDLEFIELD BANC CORP (MBCN). Click either name above to swap in a different company.

Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $19.9M, roughly 1.2× MIDDLEFIELD BANC CORP). MIDDLEFIELD BANC CORP runs the higher net margin — 26.7% vs -54.6%, a 81.3% gap on every dollar of revenue. MIDDLEFIELD BANC CORP produced more free cash flow last quarter ($3.4M vs $-11.0M).

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

Star Banc Corporation was a Cincinnati, Ohio-based regional bank holding company that acquired Firstar in 1998 and took the Firstar name; the merged bank acquired U.S. Bancorp in 2001 and took the U.S. Bancorp name. The company can trace its origins back to 1863 when it was first founded as the First National Bank of Cincinnati.

CBLL vs MBCN — Head-to-Head

Bigger by revenue
CBLL
CBLL
1.2× larger
CBLL
$24.8M
$19.9M
MBCN
Higher net margin
MBCN
MBCN
81.3% more per $
MBCN
26.7%
-54.6%
CBLL
More free cash flow
MBCN
MBCN
$14.3M more FCF
MBCN
$3.4M
$-11.0M
CBLL

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CBLL
CBLL
MBCN
MBCN
Revenue
$24.8M
$19.9M
Net Profit
$-13.5M
$5.3M
Gross Margin
87.3%
Operating Margin
-58.9%
32.2%
Net Margin
-54.6%
26.7%
Revenue YoY
18.3%
Net Profit YoY
127.4%
EPS (diluted)
$-0.35
$0.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
MBCN
MBCN
Q4 25
$24.8M
Q3 25
$22.6M
$19.9M
Q2 25
$21.2M
$20.5M
Q1 25
$20.5M
$18.0M
Q4 24
$17.5M
Q3 24
$17.2M
$16.8M
Q2 24
$16.8M
Q1 24
$16.8M
Net Profit
CBLL
CBLL
MBCN
MBCN
Q4 25
$-13.5M
Q3 25
$-13.5M
$5.3M
Q2 25
$-13.6M
$6.2M
Q1 25
$-12.8M
$4.8M
Q4 24
$4.8M
Q3 24
$-10.4M
$2.3M
Q2 24
$4.2M
Q1 24
$4.2M
Gross Margin
CBLL
CBLL
MBCN
MBCN
Q4 25
87.3%
Q3 25
88.3%
Q2 25
88.1%
Q1 25
87.9%
Q4 24
Q3 24
87.3%
Q2 24
Q1 24
Operating Margin
CBLL
CBLL
MBCN
MBCN
Q4 25
-58.9%
Q3 25
-64.8%
32.2%
Q2 25
-70.5%
35.9%
Q1 25
-69.3%
31.9%
Q4 24
33.4%
Q3 24
-57.8%
16.1%
Q2 24
28.8%
Q1 24
29.4%
Net Margin
CBLL
CBLL
MBCN
MBCN
Q4 25
-54.6%
Q3 25
-59.6%
26.7%
Q2 25
-64.4%
30.0%
Q1 25
-62.4%
26.8%
Q4 24
27.8%
Q3 24
-60.6%
13.9%
Q2 24
24.7%
Q1 24
24.9%
EPS (diluted)
CBLL
CBLL
MBCN
MBCN
Q4 25
$-0.35
Q3 25
$-0.37
$0.65
Q2 25
$-0.38
$0.76
Q1 25
$-0.36
$0.60
Q4 24
$0.60
Q3 24
$-1.85
$0.29
Q2 24
$0.52
Q1 24
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
MBCN
MBCN
Cash + ST InvestmentsLiquidity on hand
$159.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$155.3M
$224.1M
Total Assets
$195.8M
$2.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
MBCN
MBCN
Q4 25
$159.3M
Q3 25
$168.5M
Q2 25
$177.4M
Q1 25
$182.7M
Q4 24
Q3 24
$14.1M
Q2 24
Q1 24
Stockholders' Equity
CBLL
CBLL
MBCN
MBCN
Q4 25
$155.3M
Q3 25
$164.1M
$224.1M
Q2 25
$172.2M
$216.1M
Q1 25
$180.9M
$213.8M
Q4 24
$210.6M
Q3 24
$-136.0M
$210.7M
Q2 24
$206.8M
Q1 24
$205.6M
Total Assets
CBLL
CBLL
MBCN
MBCN
Q4 25
$195.8M
Q3 25
$199.5M
$2.0B
Q2 25
$207.7M
$1.9B
Q1 25
$213.5M
$1.9B
Q4 24
$1.9B
Q3 24
$47.1M
$1.9B
Q2 24
$1.8B
Q1 24
$1.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
MBCN
MBCN
Operating Cash FlowLast quarter
$-10.8M
$4.8M
Free Cash FlowOCF − Capex
$-11.0M
$3.4M
FCF MarginFCF / Revenue
-44.2%
17.0%
Capex IntensityCapex / Revenue
0.7%
7.2%
Cash ConversionOCF / Net Profit
0.91×
TTM Free Cash FlowTrailing 4 quarters
$-41.6M
$32.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
MBCN
MBCN
Q4 25
$-10.8M
Q3 25
$-11.1M
$4.8M
Q2 25
$-7.5M
$4.8M
Q1 25
$-11.4M
$8.0M
Q4 24
$17.5M
Q3 24
$6.0M
Q2 24
$3.4M
Q1 24
$5.4M
Free Cash Flow
CBLL
CBLL
MBCN
MBCN
Q4 25
$-11.0M
Q3 25
$-11.5M
$3.4M
Q2 25
$-7.6M
$4.2M
Q1 25
$-11.6M
$7.7M
Q4 24
$16.7M
Q3 24
$5.8M
Q2 24
$3.3M
Q1 24
$5.3M
FCF Margin
CBLL
CBLL
MBCN
MBCN
Q4 25
-44.2%
Q3 25
-50.8%
17.0%
Q2 25
-35.9%
20.5%
Q1 25
-56.4%
42.9%
Q4 24
95.6%
Q3 24
34.7%
Q2 24
19.3%
Q1 24
31.9%
Capex Intensity
CBLL
CBLL
MBCN
MBCN
Q4 25
0.7%
Q3 25
1.6%
7.2%
Q2 25
0.3%
3.0%
Q1 25
0.7%
1.5%
Q4 24
4.4%
Q3 24
1.0%
Q2 24
0.6%
Q1 24
0.5%
Cash Conversion
CBLL
CBLL
MBCN
MBCN
Q4 25
Q3 25
0.91×
Q2 25
0.78×
Q1 25
1.66×
Q4 24
3.60×
Q3 24
2.57×
Q2 24
0.81×
Q1 24
1.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

MBCN
MBCN

Segment breakdown not available.

Related Comparisons